Dextromethorphan/quinidine (AVP-923) phase 2 study for...

Alzheimer's & Dementia 2015 / 07 Vol. 11; Iss. 7

Dextromethorphan/quinidine (AVP-923) phase 2 study for treatment of agitation in Alzheimer’s disease: Comparing the enrolled agitation sample with the international psychogeriatric association definition of agitation in cognitive disorders (NCT01584440)

Cummings, Jeffrey L., Lyketsos, Constantine, Peskind, Elaine R., Porsteinsson, Anton P., Mintzer, Jacobo E., Scharre, Douglas W., De La Gándara, José E., Agronin, Marc, Davis, Charles S., Nguyen, Uyen
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
11
Language:
english
Journal:
Alzheimer's & Dementia
DOI:
10.1016/j.jalz.2015.06.1675
Date:
July, 2015
File:
PDF, 53 KB
english, 2015
Conversion to is in progress
Conversion to is failed